請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/40973完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 王勝仕 | |
| dc.contributor.author | Ming-Chien Hsieh | en |
| dc.contributor.author | 謝明諫 | zh_TW |
| dc.date.accessioned | 2021-06-14T17:09:37Z | - |
| dc.date.available | 2011-07-30 | |
| dc.date.copyright | 2008-07-30 | |
| dc.date.issued | 2008 | |
| dc.date.submitted | 2008-07-28 | |
| dc.identifier.citation | 1. Mills, I.A., S.L. Flaugh, M.S. Kosinski-Collins, and J.A. King, Folding and stability of the isolated Greek key domains of the long-lived human lens proteins gamma D-crystallin and gamma S-crystallin. Protein Science, 2007. 16(11): p. 2427-2444.
2. Flaugh, S.L., M.S. Kosinski-Collins, and J. King, Interdomain side-chain interactions in human gamma D crystallin influencing folding and stability. Protein Science, 2005. 14(8): p. 2030-2043. 3. Evans, P., K. Wyatt, G.J. Wistow, O.A. Bateman, B.A. Wallace, and C. Slingsby, The P23T cataract mutation causes loss of solubility of folded gamma D-crystallin. Journal of Molecular Biology, 2004. 343(2): p. 435-444. 4. Lee, J.S., J.H. Liao, S.H. Wu, and S.H. Chiou, alpha-crystallin acting as a molecular chaperonin against photodamage by UV irradiation. Journal of Protein Chemistry, 1997. 16(4): p. 283-289. 5. Hanson, S.R.A., D.L. Smith, and J.B. Smith, Deamidation and disulfide bonding in human lens gamma-crystallins. Experimental Eye Research, 1998. 67(3): p. 301-312. 6. Hanson, S.R.A., A. Hasan, D.L. Smith, and J.B. Smith, The major in vivo modifications of the human water-insoluble lens crystallins are disulfide bonds, deamidation, methionine oxidation and backbone cleavage. Experimental Eye Research, 2000. 71(2): p. 195-207. 7. Flaugh, S.L., I.A. Mills, and J. King, Glutamine deamidation destabilizes human gamma D-crystallin and lowers the kinetic barrier to unfolding. Journal of Biological Chemistry, 2006. 281(41): p. 30782-30793. 8. Srivastava, O.P. and K. Srivastava, Degradation of gamma D- and gamma s-crystallins in human lenses. Biochemical and Biophysical Research Communications, 1998. 253(2): p. 288-294. 9. Bloemendal, H., W. de Jong, R. Jaenicke, N.H. Lubsen, C. Slingsby, and A. Tardieu, Ageing and vision: structure, stability and function of lens crystallins. Progress in Biophysics & Molecular Biology, 2004. 86(3): p. 407-485. 10. MacCoss, M.J., W.H. McDonald, A. Saraf, R. Sadygov, J.M. Clark, J.J. Tasto, K.L. Gould, D. Wolters, M. Washburn, A. Weiss, J.I. Clark, and J.R. Yates, Shotgun identification of protein modifications from protein complexes and lens tissue. Proceedings of the National Academy of Sciences of the United States of America, 2002. 99(12): p. 7900-7905. 11. Iwaki, T., A. Kumeiwaki, and J.E. Goldman, Cellular-Distribution of Alpha-B-Crystallin in Non-Lenticular Tissues. Journal of Histochemistry & Cytochemistry, 1990. 38(1): p. 31-39. 12. Jobby, M.K. and Y. Sharma, Rapid purification of recombinant beta B2-crystallin using hydrophobic interaction chromatography. Protein Expression and Purification, 2003. 28(1): p. 158-164. 13. Wang, X.H., C.M. Garcia, Y.B. Shui, and D.C. Beebe, Expression and regulation of alpha-, beta-, and gamma-crystallins in mammalian lens epithelial cells. Investigative Ophthalmology & Visual Science, 2004. 45(10): p. 3608-3619. 14. Siezen, R.J., J.A. Thomson, E.D. Kaplan, and G.B. Benedek, Human Lens Gamma-Crystallins - Isolation, Identification, and Characterization of the Expressed Gene-Products. Proceedings of the National Academy of Sciences of the United States of America, 1987. 84(17): p. 6088-6092. 15. Tardieu, A., F. Veretout, B. Krop, and C. Slingsby, Protein Interactions in the Calf Eye Lens - Interactions between Beta-Crystallins Are Repulsive Whereas in Gamma-Crystallins They Are Attractive. European Biophysics Journal with Biophysics Letters, 1992. 21(1): p. 1-12. 16. Foster, A., Cataract - a global perspective: output, outcome and outlay. Eye, 1999. 13: p. 449-453. 17. Sandilands, A., A.M. Hutcheson, H.A. Long, A.R. Prescott, G. Vrensen, J. Loster, N. Klopp, R.B. Lutz, J. Graw, S. Masaki, C.M. Dobson, C.E. MacPhee, and R.A. Quinlan, Altered aggregation properties of mutant gamma-crystallins cause inherited cataract. Embo Journal, 2002. 21(22): p. 6005-6014. 18. McManus, J.J., A. Lomakin, O. Ogun, A. Pande, M. Basan, J. Pande, and G.B. Benedek, Altered phase diagram due to a single point mutation in human gamma D-crystallin. Proceedings of the National Academy of Sciences of the United States of America, 2007. 104(43): p. 16856-16861. 19. Stephan, D.A., E. Gillanders, D. Vanderveen, D. Freas-Lutz, G. Wistow, A.D. Baxevanis, C.M. Robbins, A. VanAuken, M.I. Quesenberry, J. Bailey-Wilson, S.H.H. Juo, J.M. Trent, L. Smith, and M.J. Brownstein, Progressive juvenile-onset punctate cataracts caused by mutation of the gamma D-crystallin gene. Proceedings of the National Academy of Sciences of the United States of America, 1999. 96(3): p. 1008-1012. 20. Nandrot, E., C. Slingsby, A. Basak, M. Cherif-Chefchaouni, B. Benazzouz, Y. Hajaji, S. Boutayeb, O. Gribouval, L. Arbogast, A. Berraho, M. Abitbol, and L. Hilal, Gamma-D crystallin gene (CRYGD) mutation causes autosomal dominant congenital cerulean cataracts. Journal of Medical Genetics, 2003. 40(4): p. 262-267. 21. Graw, J., J. Loster, D. Soewarto, H. Fuchs, A. Reis, E. Wolf, R. Balling, and M.H. de Angelis, V76D mutation in a conserved gamma D-crystallin region leads to dominant cataracts in mice. Mammalian Genome, 2002. 13(8): p. 452-455. 22. Pande, A., O. Annunziata, N. Asherie, O. Ogun, G.B. Benedek, and J. Pande, Decrease in protein solubility and cataract formation caused by the Pro23 to Thr mutation in human gamma D-crystallin. Biochemistry, 2005. 44(7): p. 2491-2500. 23. Shentu, X.C., K. Yao, W. Xu, S. Zheng, S.N. Hu, and X.H. Gong, Special fasciculiform cataract caused by a mutation in the gamma D-crystallin gene. Molecular Vision, 2004. 10(28-30): p. 233-239. 24. Gu, J.Z., Y.H. Qi, L. Wang, J. Wang, L.S. Shi, H. Lin, X. Li, H. Su, and S.Z. Huang, A new congenital nuclear cataract caused by a missense mutation in the gamma D-crystallin gene (CRYGD) in a Chinese family. Molecular Vision, 2005. 11(116): p. 971-976. 25. Gu, F., R. Li, X.X. Ma, L.S. Shi, S.Z. Huang, and X. Ma, A missense mutation in the gamma D-crystallin gene GRYGD associated with autosomal dominant congenital cataract in a Chinese family. Molecular Vision, 2006. 12(2-3): p. 26-31. 26. Hansen, L., W.L. Yao, H. Eiberg, K.W. Kjaer, K. Baggesen, J.F. Hejtmancik, and T. Rosenberg, Genetic heterogeneity in microcornea-cataract: Five novel mutations in CRYAA, CRYGD, and GJA8. Investigative Ophthalmology & Visual Science, 2007. 48(9): p. 3937-3944. 27. Kosinski-Collins, M.S., S.L. Flaugh, and J. King, Probing folding and fluorescence quenching in human gamma D crystallin Greek key domains using triple tryptophan mutant proteins. Protein Science, 2004. 13(8): p. 2223-2235. 28. Chen, J.J., S.L. Flaugh, P.R. Callis, and J. King, Mechanism of the highly efficient quenching of tryptophan fluorescence in human gamma D-crystallin. Biochemistry, 2006. 45(38): p. 11552-11563. 29. Santhiya, S.T., M.S. Manohar, D. Rawlley, P. Vijayalakshmi, P. Namperumalsamy, P.M. Gopinath, J. Loster, and J. Graw, Novel mutations in the gamma-crystallin genes cause autosomal dominant congenital cataracts. Journal of Medical Genetics, 2002. 39(5): p. 352-358. 30. Talla, V., C. Narayanan, N. Srinivasan, and D. Balasubramanian, Mutation causing self-aggregation in human gamma C-crystallin leading to congenital cataract. Investigative Ophthalmology & Visual Science, 2006. 47(12): p. 5212-5217. 31. Pande, A., J. Pande, N. Asherie, A. Lomakin, O. Ogun, J.A. King, N.H. Lubsen, D. Walton, and G.B. Benedek, Molecular basis of a progressive juvenile-onset hereditary cataract. Proceedings of the National Academy of Sciences of the United States of America, 2000. 97(5): p. 1993-1998. 32. Kmoch, S., J. Brynda, B. Asfaw, K. Bezouska, P. Novak, P. Rezacova, L. Ondrova, M. Filipec, J. Sedlacek, and M. Elleder, Link between a novel human gamma D-crystallin allele and a unique cataract phenotype explained by protein crystallography. Human Molecular Genetics, 2000. 9(12): p. 1779-1786. 33. Pande, A., J. Pande, N. Asherie, A. Lomakin, O. Ogun, J. King, and G.B. Benedek, Crystal cataracts: Human genetic cataract caused by protein crystallization. Proceedings of the National Academy of Sciences of the United States of America, 2001. 98(11): p. 6116-6120. 34. Kosinski-Collins, M.S. and J. King, In vitro unfolding, refolding, and polymerization of human gamma D crystallin, a protein involved in cataract formation. Protein Science, 2003. 12(3): p. 480-490. 35. Goldin, A., J.A. Beckman, A.M. Schmidt, and M.A. Creager, Advanced glycation end products - Sparking the development of diabetic vascular injury. Circulation, 2006. 114(6): p. 597-605. 36. Frye, E.B., T.P. Degenhardt, S.R. Thorpe, and J.W. Baynes, Role of the Maillard reaction in aging of tissue proteins - Advanced glycation end product-dependent increase in imidazolium cross-links in human lens proteins. Journal of Biological Chemistry, 1998. 273(30): p. 18714-18719. 37. Dunn, J.A., J.S. Patrick, S.R. Thorpe, and J.W. Baynes, Oxidation of Glycated Proteins - Age-Dependent Accumulation of N-Epsilon-(Carboxymethyl)Lysine in Lens Proteins. Biochemistry, 1989. 28(24): p. 9464-9468. 38. Robinson, N.E. and A. Robinson, Molecular clocks : deamidation of asparaginyl and glutaminyl residues in peptides and proteins. 2004, Cave Junction, OR: Althouse Press. 39. Gerrard, A.G.M.a.J.A., The Maillard Reaction and Food Protein Crosslinking. Progress in Food Biopolymer Research, 2005. 1: p. 69-86. 40. Lapko, V.N., D.L. Smith, and J.B. Smith, Methylation and carbamylation of human gamma-crystallins. Protein Science, 2003. 12(8): p. 1762-1774. 41. 蘇遠志, 黃., 微生物利用之現況及展望. 1997: 微生物化學工程學. p 24-46. 42. Sun, X.L., N. Frearson, C. Kirk, W.T. Jones, D. Harvey, J. Rakonjac, T. Foster, and T. Al-Samarrai, An E. coli expression system optimized for DELLA proteins. Protein Expression and Purification, 2008. 58(1): p. 168-174. 43. Gamboa-Melendez, M., P. Gomez, M.B. De Leon, M. Rojas-Sierra, and B. Cisneros, Expression and purification of human dystrophin Dp71 in Escherichia coli. Annals of Microbiology, 2005. 55(2): p. 157-161. 44. Schmidt, F.R., Recombinant expression systems in the pharmaceutical industry. Applied Microbiology and Biotechnology, 2004. 65(4): p. 363-372. 45. Han, K., H.C. Lim, and J. Hong, Acetic-Acid Formation in Escherichia-Coli Fermentation. Biotechnology and Bioengineering, 1992. 39(6): p. 663-671. 46. Luli, G.W. and W.R. Strohl, Comparison of Growth, Acetate Production, and Acetate Inhibition of Escherichia-Coli Strains in Batch and Fed-Batch Fermentations. Applied and Environmental Microbiology, 1990. 56(4): p. 1004-1011. 47. De Mey, M., S. De Maeseneire, W. Soetaert, and E. Vandamme, Minimizing acetate formation in E-coli fermentations. Journal of Industrial Microbiology & Biotechnology, 2007. 34(11): p. 689-700. 48. Dittrich, C.R., R.V. Vadali, G.N. Bennett, and K.Y. Sant, Redistribution of metabolic fluxes in the central aerobic metabolic pathway of E-coli mutant strains with deletion of the ackA-pta and poxB pathways for the synthesis of isoamyl acetate. Biotechnology Progress, 2005. 21(2): p. 627-631. 49. Eiteman, M.A. and E. Altman, Overcoming acetate in Escherichia coli recombinant protein fermentations. Trends in Biotechnology, 2006. 24(11): p. 530-536. 50. Kim, C.H., J.Y. Lee, M.G. Kim, K.B. Song, J.W. Seo, B.H. Chung, S.J. Chang, and S.K. Rhee, Fermentation strategy to enhance plasmid stability during the cultivation of Escherichia coli for the production of recombinant levansucrase. Journal of Fermentation and Bioengineering, 1998. 86(4): p. 391-394. 51. 洪金榮, 以基因重組大腸桿菌生產白細胞介素20號:誘導劑添加方式之研究. 2003: 成大化工. 52. Chen, X.A., Z.N. Xu, P.L. Cen, and W.K.R. Wong, Enhanced plasmid stability and production of hEGF by immobilized recombinant E-coli JM101. Biochemical Engineering Journal, 2006. 28(3): p. 215-219. 53. Kim, M., C. Elvin, A. Brownlee, and R. Lyons, High yield expression of recombinant pro-resilin: Lactose-induced fermentation in E coli and facile purification. Protein Expression and Purification, 2007. 52(1): p. 230-236. 54. Lan, P.C., C.F. Tseng, M.C. Lin, and C.A. Chang, Expression and purification of human placenta lactogen in Escherichia coli. Protein Expression and Purification, 2006. 46(2): p. 285-293. 55. Jobby, M.K. and Y. Sharma, Purification of a crystallin domain of Yersinia crystallin from inclusion bodies and its comparison to native protein from the soluble fraction. Biomedical Chromatography, 2006. 20(9): p. 956-963. 56. Chang, C.C., X.C. Yeh, H.T. Lee, P.Y. Lin, and L.S. Kan, Refolding of lysozyme by quasistatic and direct dilution reaction paths: A first-order-like state transition. Physical Review E, 2004. 70(1). 57. Al-Samarrai, T.H., C.A. Kirk, W.T. Jones, D. Harvey, and X.L. Sun, Expression in Escherichia coli and in vitro refolding of the plant transcription factor Arabidopsis thaliana RGL3. Protein Expression and Purification, 2007. 53(2): p. 289-292. 58. Clark, E.D.B., Refolding of recombinant proteins. Current Opinion in Biotechnology, 1998. 9(2): p. 157-163. 59. Sorensen, H.P., H.U. Sperling-Petersen, and K.K. Mortensen, Dialysis strategies for protein refolding: preparative streptavidin production. Protein Expression and Purification, 2003. 31(1): p. 149-154. 60. West, S.M., J.B. Chaudhuri, and J.A. Howell, Improved protein refolding using hollow-fibre membrane dialysis. Biotechnology and Bioengineering, 1998. 57(5): p. 590-599. 61. Sakono, M., T. Maruyama, N. Kamiya, and M. Goto, Refolding of denatured carbonic anhydrase B by reversed micelles formulated with nonionic surfactant. Biochemical Engineering Journal, 2004. 19(3): p. 217-220. 62. Sakono, M., Y.M. Kawashima, H. Ichinose, T. Maruyama, N. Kamiya, and M. Goto, Direct refolding of inclusion bodies using reversed micelles. Biotechnology Progress, 2004. 20(6): p. 1783-1787. 63. Wang, C.Z., L.L. Wang, and X.D. Geng, High recovery refolding of rhG-CSF from Escherichia coli, using urea gradient size exclusion chromatography. Biotechnology Progress, 2008. 24(1): p. 209-213. 64. Wang, S.S.S., C.K. Chang, and H.S. Liu, Effect of sample loop dimension on lysozyme refolding in size-exclusion chromatography. Journal of Chromatography A, 2007. 1161(1-2): p. 56-63. 65. Shen, Y.H., Y. Takayama, Y.M. Wei, E. Harada, E. Nakatani, and H. Akutsu, Refolding of mis-folded recombinant cytochrome c(3) with strong cation exchange chromatography. Journal of Liquid Chromatography & Related Technologies, 2007. 30(5-8): p. 1051-1059. 66. Xiao, H.G., T. Tanaka, M. Ogawa, and R.Y. Yada, Expression and enzymatic characterization of the soluble recombinant plasmepsin I from Plasmodium falciparum. Protein Engineering Design & Selection, 2007. 20(12): p. 625-633. 67. Wohlkonig, A., M. Senechal, F. Dewitte, K. Backers, C. Erneux, and V. Villeret, Expression and purification in high yield of a functionally active recombinant human Type I inositol(1,4,5)P-3 5-phosphatase. Protein Expression and Purification, 2007. 55(1): p. 69-74. 68. Richez, C., J. Boetzel, N. Floquet, K. Koteshwar, J. Stevens, B. Badet, and M.A. Badet-Denisot, Expression and purification of active human internal HiS(6)-tagged L-glutamine: D-fructose-6P amidotransferase I. Protein Expression and Purification, 2007. 54(1): p. 45-53. 69. Qian, R.H., Z.H. Xiao, C.W. Zhang, W.Y. Chu, Z.J. Mao, and L. Yu, Expression and purification of two major outer membrane proteins from Vibrio alginolyticus. World Journal of Microbiology & Biotechnology, 2008. 24(2): p. 245-251. 70. Hay, R.E., U.P. Andley, and J.M. Petrash, Expression of Recombinant Bovine Gamma-B-Crystallin, Gamma-C-Crystallin and Gamma-D-Crystallin and Correlation with Native Proteins. Experimental Eye Research, 1994. 58(5): p. 573-584. 71. Marti, D., J. Schaller, B. Ochensberger, and E.E. Rickli, Expression, Purification and Characterization of the Recombinant Kringle 2 and Kringle 3 Domains of Human Plasminogen and Analysis of Their Binding-Affinity for Omega-Aminocarboxylic Acids. European Journal of Biochemistry, 1994. 219(1-2): p. 455-462. 72. Mark, J.K., S. Smith, and M.A. Hefford, Over-expression and refolding of MAP kinase phosphatase 3. Protein Expression and Purification, 2007. 54(2): p. 253-260. 73. Luo, M.J., W.X. Liu, X.Y. Yang, Y. Xu, F. Yan, P. Huang, and F. Chen, Cloning, expression, and antitumor activity of recombinant protein of curcin. Russian Journal of Plant Physiology, 2007. 54(2): p. 202-206. 74. Sunitha, K., Y.O. Kim, J.K. Lee, and T.K. Oh, Statistical optimization of seed and induction conditions to enhance phytase production by recombinant Escherichia coli. Biochemical Engineering Journal, 2000. 5(1): p. 51-56. 75. Tan, H.D., J.X. Wang, and Z.B. Zhao, Purification and refolding optimization of recombinant bovine enterokinase light chain overexpressed in Escherichia coli. Protein Expression and Purification, 2007. 56(1): p. 40-47. 76. Grossman, T.H., E.S. Kawasaki, S.R. Punreddy, and M.S. Osburne, Spontaneous cAMP-dependent derepression of gene expression in stationary phase plays a role in recombinant expression instability. Gene, 1998. 209(1-2): p. 95-103. 77. Pan, S.H. and B.A. Malcolm, Reduced background expression and improved plasmid stability with pET vectors in BL21 (DE3). Biotechniques, 2000. 29(6): p. 1234-+. 78. Gupta, R., P. Sharma, and V.V. Vyas, Effect of Growth Environment on the Stability of a Recombinant Shuttle Plasmid, Pcpps-31, in Escherichia-Coli. Journal of Biotechnology, 1995. 41(1): p. 29-37. 79. Chen, C.W., B.C. Lei, K.W. Yeh, and K.J. Duan, Recombinant sweet potato sporamin production via glucose/pH control in fed-batch cultures of Saccharomyces cerevisiae. Process Biochemistry, 2003. 38(8): p. 1223-1229. 80. 楊美桂, 微生物學. 2003: 藝軒圖書出版社. 81. 沈倩如, 利用基因重組之大腸桿菌生產盤尼西林醯化 82. Adinarayana, K. and P. Ellaiah, Response surface optimization of the critical medium components for the production of alkaline protease by a newly isolated Bacillus sp. Journal of Pharmacy and Pharmaceutical Sciences, 2002. 5(3): p. 281-287. 83. Balusu, R., R.R. Paduru, S.K. Kuravi, G. Seenayya, and G. Reddy, Optimization of critical medium components using response surface methodology for ethanol production from cellulosic biomass by Clostridium thermocellum SS19. Process Biochemistry, 2005. 40(9): p. 3025-3030. 84. Barrington, S. and J.W. Kim, Response surface optimization of medium components for citric acid production by Aspergillus niger NRRL 567 grown in peat moss. Bioresource Technology, 2008. 99(2): p. 368-377. 85. Zhu, C.H., F.P. Lu, Y.N. He, J.K. Zhang, and L.X. Du, Statistical optimization of medium components for avilamycin production by Streptomyces viridochromogenes Tu57-1 using response surface methodology. Journal of Industrial Microbiology & Biotechnology, 2007. 34(4): p. 271-278. 86. Liu, G.Q. and X.L. Wang, Optimization of critical medium components using response surface methodology for biomass and extracellular polysaccharide production by Agaricus blazei. Applied Microbiology and Biotechnology, 2007. 74(1): p. 78-83. 87. Soni, P., M. Singh, A.L. Kamble, and U.C. Banerjee, Response surface optimization of the critical medium components for carbonyl reductase production by Candida viswanathii MTCC 5158. Bioresource Technology, 2007. 98(4): p. 829-833. 88. Kaushik, R., S. Saran, J. Isar, and R.K. Saxena, Statistical optimization of medium components and growth conditions by response surface methodology to enhance lipase production by Aspergillus carneus. Journal of Molecular Catalysis B-Enzymatic, 2006. 40(3-4): p. 121-126. 89. Prapulla, S.G., Z. Jacob, N. Chand, D. Rajalakshmi, and N.G. Karanth, Maximization of Lipid Production by Rhodotorula-Gracilis Cfr-1 Using Response-Surface Methodology. Biotechnology and Bioengineering, 1992. 40(8): p. 965-970. 90. Puri, S., Q.K. Beg, and R. Gupta, Optimization of alkaline protease production from Bacillus sp by response surface methodology. Current Microbiology, 2002. 44(4): p. 286-290. 91. Mao, X.B., T. Eksriwong, S. Chauvatcharin, and J.J. Zhong, Optimization of carbon source and carbon/nitrogen ratio for cordycepin production by submerged cultivation of medicinal mushroom Cordyceps militaris. Process Biochemistry, 2005. 40(5): p. 1667-1672. 92. 陳特良, 誘導後比生長速率對基因重組大腸桿菌生產肌酸酵素的影響. 2004: 成大化工. 93. Castan, A. and S.O. Enfors, Characteristics of a DO-controlled fed-batch culture of Escherichia coli. Bioprocess Engineering, 2000. 22(6): p. 509-515. 94. Kilikian, B.V., I.D. Suarez, C.W. Liria, and A.K. Gombert, Process strategies to improve heterologous protein production in Escherichia coli under lactose or IPTG induction. Process Biochemistry, 2000. 35(9): p. 1019-1025. 95. Wong, H.H., Y.C. Kim, S.Y. Lee, and H.N. Chang, Effect of post-induction nutrient feeding strategies on the production of bioadhesive protein in Escherichia coli. Biotechnology and Bioengineering, 1998. 60(3): p. 271-276. 96. Flaugh, S.L., M.S. Kosinski-Collins, and J. King, Contributions of hydrophobic domain interface interactions to the folding and stability of human gamma D-crystallin. Protein Science, 2005. 14(3): p. 571-581. 97. Mojsin, M., G. Nikcevic, N.K. Kovacevic, T. Savic, I. Petrovic, and M. Stevanovic, Purification and functional analysis of the recombinant protein isolated from E-coli by employing three different methods of bacterial lysis. Journal of the Serbian Chemical Society, 2005. 70(7): p. 943-950. 98. Nossal, N.G. and L.A. Heppel, Release of Enzymes by Osmotic Shock from Escherichia Coli in Exponential Phase. Journal of Biological Chemistry, 1966. 241(13): p. 3055-&. 99. Rathore, A.S., R.E. Bilbrey, and D.E. Steinmeyer, Optimization of an osmotic shock procedure for isolation of a protein product expressed in E-coli. Biotechnology Progress, 2003. 19(5): p. 1541-1546. 100. Feng, Y., M. Wan, Z.M. Xiang, H.F. Wei, X.P. Hu, Y.M. Wang, L. Dai, M.L. Fang, X.F. Zhang, Y.L. Yu, and L.Y. Wang, Purification of a non-tagged recombinant BCG heat shock protein 65-Her2 peptide fusion protein from Escherichia coli. Protein Expression and Purification, 2007. 53(2): p. 390-395. 101. Latchman, D.S., Transcription Factors - an Overview. International Journal of Experimental Pathology, 1993. 74(5): p. 417-422. 102. Johnson, B.H. and M.H. Hecht, Recombinant Proteins Can Be Isolated from Escherichia-Coli-Cells by Repeated Cycles of Freezing and Thawing. Bio-Technology, 1994. 12(13): p. 1357-1360. 103. Ribela, M., I.M.C. Camargo, J.E. Oliveira, and P. Bartolini, Single-step purification of recombinant human growth hormone (hGH) directly from bacterial osmotic shock fluids, for the purpose of I-125-hGH preparation. Protein Expression and Purification, 2000. 18(2): p. 115-120. 104. Zhu, Z.Y., D.P. Sun, and V.L. Davidson, Localization of periplasmic redox proteins of Alcaligenes faecalis by a modified general method for fractionating gram-negative bacteria. Journal of Bacteriology, 1999. 181(20): p. 6540-6542. 105. Sauer, T. and E.A. Galinski, Bacterial milking: A novel bioprocess for production of compatible solutes. Biotechnology and Bioengineering, 1998. 57(3): p. 306-313. 106. McPherson, A., Crystallization of Macromolecules - General-Principles. Methods in Enzymology, 1985. 114: p. 112-120. 107. Tessier, P.M., S.D. Vandrey, B.W. Berger, R. Pazhianur, S.I. Sandler, and A.M. Lenhoff, Self-interaction chromatography: a novel screening method for rational protein crystallization. Acta Crystallographica Section D-Biological Crystallography, 2002. 58: p. 1531-1535. 108. Green, A.A., Studies in the physical chemistry of the proteins X. The solubility of hemoglobin in solutions of chlorides and sulfates of varying concentration. Journal of Biological Chemistry, 1932. 95(1): p. 47-66. 109. Srivastava, O.P. and K. Srivastava, Purification of gamma-crystallin from human lenses by acetone precipitation method. Current Eye Research, 1998. 17(11): p. 1074-1081. 110. Johnson, R.D. and F.H. Arnold, Multipoint Binding and Heterogeneity in Immobilized Metal Affinity-Chromatography. Biotechnology and Bioengineering, 1995. 48(5): p. 437-443. 111. Amor-Mahjoub, M., J.P. Suppini, N. Gomez-Vrielyunck, and M. Ladjimi, The effect of the hexahistidine-tag in the oligomerization of HSC70 constructs. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences, 2006. 844(2): p. 328-334. 112. Jones, C., A. Patel, S. Griffin, J. Martin, P. Young, K. Odonnell, C. Silverman, T. Porter, and I. Chaiken, Current Trends in Molecular Recognition and Bioseparation. Journal of Chromatography A, 1995. 707(1): p. 3-22. 113. Hang, Q., L. Woods, M. Feiss, and C.E. Catalano, Cloning, expression, and biochemical characterization of hexahistidine-tagged terminase proteins. Journal of Biological Chemistry, 1999. 274(22): p. 15305-15314. 114. Wang, B.L., Y. Xu, C.Q. Wu, Y.M. Xu, and H.H. Wang, Cloning, expression, and refolding of a secretory protein ESAT-6 of Mycobacterium tuberculosis. Protein Expression and Purification, 2005. 39(2): p. 184-188. 115. Potenza, N., V. Salvatore, D. Raimondo, D. Falanga, V. Nobile, D.L. Peterson, and A. Russo, Optimized expression from a synthetic gene of an untagged RNase H domain of human hepatitis B virus polymerase which is enzymatically active. Protein Expression and Purification, 2007. 55(1): p. 93-99. 116. Malik, A., M. Jenzsch, A. Lubbert, R. Rudolph, and B. Sohling, Periplasmic production of native human proinsulin as a fusion to E-coli ecotin. Protein Expression and Purification, 2007. 55(1): p. 100-111. 117. Zirk, K. and H. Poetzschke, On the suitability of refractometry for the analysis of glucose in blood-derived fluids. Medical Engineering & Physics, 2004. 26(6): p. 473-481. 118. Ma, Z.X., S.R.A. Hanson, K.J. Lampi, L.L. David, D.L. Smith, and J.B. Smith, Age-related changes in human lens crystallins identified by HPLC and mass spectrometry. Experimental Eye Research, 1998. 67(1): p. 21-30. 119. Basak, A., O. Bateman, C. Slingsby, A. Pande, N. Asherie, O. Ogun, G.B. Benedek, and J. Pande, High-resolution X-ray crystal structures of human gamma D crystallin (1.25 angstrom) and the R58H mutant (1.15 angstrom) associated with aculeiform cataract. Journal of Molecular Biology, 2003. 328(5): p. 1137-1147. 120. Lowry, O.H., N.J. Rosebrough, A.L. Farr, and R.J. Randall, Protein Measurement with the Folin Phenol Reagent. Journal of Biological Chemistry, 1951. 193(1): p. 265-275. 121. Smith, P.K., R.I. Krohn, G.T. Hermanson, A.K. Mallia, F.H. Gartner, M.D. Provenzano, E.K. Fujimoto, N.M. Goeke, B.J. Olson, and D.C. Klenk, Measurement of Protein Using Bicinchoninic Acid. Analytical Biochemistry, 1985. 150(1): p. 76-85. 122. Bradford, M.M., Rapid and Sensitive Method for Quantitation of Microgram Quantities of Protein Utilizing Principle of Protein-Dye Binding. Analytical Biochemistry, 1976. 72(1-2): p. 248-254. 123. Tomaszewska-Gras, J., J. Kijowski, and F.J.G. Schreurs, Quantitative determination of titin and nebulin in poultry meat by SDS-PAGE with an internal standard. Meat Science, 2002. 62(1): p. 61-66. 124. Atanassov, C.L., N. Seiler, and G. Rebel, Reduction of ammonia formation in cell cultures by L-alanyl-L-glutamine requires optimization of the dipeptide concentration. Journal of Biotechnology, 1998. 62(2): p. 159-162. 125. 劉建福, 王., 許時嬰, 碳源對K. fragilis LFS-8611 β-D-半乳糖甘酉每合成的影響. industrial microbiology, 2004. 34(3): p. 24-27. 126. 李梅菁, 以基質輔助雷射脫附游離飛行時間質譜法分析血液中微量元素的成分, in 國立中山大學化學所. 2001. 127. Zhao, X.Y., H.X. Li, S.F. Liang, Z. Yuan, F. Yan, X.Z. Ruan, J. You, S.Q. Xiong, M.H. Tang, and Y.Q. Wei, Soluble expression of human DRRI (down-regulated in renal cell carcinoma I) in Escherichia coli and preparation of its polyclonal antibodies. Biotechnology and Applied Biochemistry, 2008. 49: p. 17-23. 128. Asiedu, C., V. Guarcello, L. Deckard, U. Jargal, B. Gansuvd, E.P. Acosta, and J.M. Thomas, Cloning and characterization of recombinant rhesus macaque IL-10/FCala-ala fusion protein: A potential adjunct for tolerance induction strategies. Cytokine, 2007. 40(3): p. 183-192. 129. Wang, S.H., B.S. Zhao, S.C. Zhang, and H.F. Ji, Cloning, expression, purification, and characterization of AmphiTip30, a member of short-chain dehydrogenases/reductases family from the amphioxus Branchiostoma belcheri tsingtauense. Protein Expression and Purification, 2008. 57(1): p. 63-71. 130. De Stefano, L., A. Vitale, I. Rea, M. Staiano, L. Rotiroti, T. Labella, I. Rendina, V. Aurilia, M. Rossi, and S. D'Auria, Enzymes and proteins from extremophiles as hyperstable probes in nanotechnology: the use of D-trehalose/D-maltose-binding protein from the hyperthermophilic archaeon Thermococcus litoralis for sugars monitoring. Extremophiles, 2008. 12(1): p. 69-73. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/40973 | - |
| dc.description.abstract | 本研究是利用載有基因重組質體 (pQE1) 之大腸桿菌 M15/pREP4來生產human γD crystallin (HGDC),並利用純化方法將HGDC與大腸桿菌自身雜蛋白分離。在第一部份之實驗中我們透過調整大腸桿菌之生長環境,如pH值、誘導劑IPTG的添加量以及添加時機、溶氧量、添加不同碳源、利用乳糖進行誘導、與變更培養液成分之比例等方式,找出最適合大腸桿菌生產HGDC 之環境。於第二部分之實驗中,我們利用acetone沉澱法、親和性吸附層析、及離心過濾等方式,將HGDC與雜蛋白分離,試圖獲得高純度之HGDC溶液,並探討回收率與純化方法之間之關係。
由我們的實驗結果得知以下結論:(1) 培養基起始pH值對於大腸桿菌生長並無明顯之影響,但是以pH值為7時HGDC產量稍高。(2) IPTG的添加為菌體濃度(OD600)達到0.6時,加入0.1mM時最佳。(3) 當溶氧量較高時,細胞生長情況以及HGDC產量均比溶氧量較低時為佳。(4) 添加葡萄糖、半乳糖、及甘油等碳源對於菌體生長以及HGDC的生產均無明顯之提升。(5) 利用乳糖進行誘導時,所獲得之HGDC產量與利用IPTG誘導時產量相近。(6) 透過增加LB培養液中tryptone與yeast extract的濃度,可以有效提升HGDC生產及菌體濃度(OD600)。(7) 透過acetone沉澱法純化時,可獲得接近90%之蛋白質回收率,純度亦可提升兩倍。(8) 利用親和性吸附純化時,可將HGDC純度提高至92%左右,而回收率為17~32%左右。(9) 最後我們利用離心過濾方式,進一步純化親和性吸附產物時,可以得到近乎100%純度之HGDC溶液。 | zh_TW |
| dc.description.abstract | Abstract
In this thesis, we used E. coli M15(pREP4), which harbors the plasmid pQE1, to express human γD crystallin (HGDC). After expression, several purification methods were utilized to separate HGDC from the other unwanted proteins. In the first part, we investigated the parameters such as pH of medium, the concentration of IPTG, and the timing of IPTG addition, the dissolved oxygen concentration, the type of carbon source, induction with lactose, the composition of LB medium, and tried to obtain the optimum expression environment for HGDC in E. coli. In the second part, acetone precipitation, affinity chromatography, and ultra-filtration were employed to purify HGDC from the other proteins. In order to obtain the solution with high purity of HGDC, attempts were also made to examine the relationship between the protine yield and the purification methods. Our results can be summarized as follows: (1) The growth of E. coli was not significantly affedcted by the initial pH value of medium. However, in comparison with those obtained at other pH values, a slightly higher yield of HGDC was achieved as the initial pH was set at 7.0. (2) The optimum condition for IPTG addition was found to be OD600 = 0.6 and final concentration = 0.1 mM. (3) Better cell growth and yield of HGDC were observed when the amount of dissolved oxygen was higher. (4) No considerable enhancements in the cell growth and the HGDC production were perceived as glucose, galactose, or glycerol was used as the carbon source. (5) Comparable amouts of HGDC were abtained from the expressions of E. coli with IPTG induction and lactose induction. (6) Through increasing the concentrations of tryptone and yeast extract of LB medium, the productivity of HGDC and the cell density (or OD600) were able to be effectively enhanced. (7) About 90% of the yield and two-fold of the purity were obtained when the protein was purified via acetone precipitation. (8) Using affinity chromatography, the purity and the yield of HGDC were found to be ~92% and ~17-32%, respectively.(9) It was observed that almost 100% pure HGDC solution could be acquired if the product from affinity chromatography was further purified with the ultra-filtration method. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-14T17:09:37Z (GMT). No. of bitstreams: 1 ntu-97-R95524026-1.pdf: 2116131 bytes, checksum: b73a25ee316f7accd612a017b493b74e (MD5) Previous issue date: 2008 | en |
| dc.description.tableofcontents | 目錄
摘要 I 目錄 IV 圖目錄 VI 表目錄 IX 第一章 緒論 1 第二章 文獻回顧 3 2.1 水晶體內的蛋白質 3 2.1.1研究水晶體內crystallin 的重要性 3 2.1.2 Crystallin 的分類 4 2.2 白內障(cataract)與HGDC(Human Gamma D Crystallin)之關聯 6 2.2.1 水晶體內的HGDC 8 2.2.2 突變對於HGDC的影響 8 2.2.3 後修飾 (post modification) 對於HGDC的影響 10 2.3 蛋白質表現 12 2.3.1 利用大腸桿菌來表現蛋白質 12 2.3.2 蛋白質基因重組工程 14 2.3.3 培養基 18 2.3.4 發酵策略介紹 23 2.4 蛋白質的純化 24 2.4.1 破菌 24 2.4.2 蛋白質分離技術 27 2.4.2.1沉澱法 27 2.4.2.2 層析 (chromatography) 30 2.4.2.3 HGDC純化策略 39 2.4.2.4 蛋白質定量方法 41 第三章 實驗材料與方法 45 3.1 菌株與質體 45 3.2 培養基(medium) 45 3.3 實驗藥品 47 3.5 培養方法以及蛋白質誘導 49 3.5.1 預培養 49 3.5.2 主培養 49 3.6 純化方法 55 3.6.1 acetone沉澱純化 55 3.6.2 親和性吸附純化 56 3.6.3 離心過濾 57 3.7 分析方法 57 3.7.1 菌體濃度之測定 57 3.7.2總蛋白質濃度測定 58 3.7.3 HGDC濃度測定 58 第四章 蛋白質的生產策略 61 4.1 環境因素對於菌種生長以及蛋白質產量之影響 61 4.1.1培養基之初始pH值對於菌體生長以及蛋白質產量之影響 61 4.1.2 IPTG對於菌體生長以及蛋白質產量之影響 65 4.1.3 培養基中之溶氧對於菌體生長以及蛋白質產量之影響 72 4.1.4 添加物對於菌體生長以及蛋白質產量之影響 77 4.1.5 利用lactose以及IPTG作為誘導劑之比較 86 4.2 改變培養基的組成對於菌種生長以及蛋白質產量之影響 89 4.2.1 one-time-one-factor 89 4.2.2 利用RSM來改良LB培養液的配方 95 第五章 蛋白質的純化策略 104 5.1 利用acetone沉澱法純化HGDC 104 5.1.1 利用不同濃度之acetone將HGDC進行純化 104 5.1.2 改變蛋白質溶液與acetone混合時間 109 5.2 親和性吸附層析 113 5.2.1 將親和性吸附凝膠固定在管柱中的純化效果 113 5.2.2 利用批次方式(batch)進行親和性吸附純化 117 5.3 離心過濾 124 第六章 結論 128 參考文獻 130 附錄 142 附錄A 乾菌重對細胞濃度(OD600)之檢量線 142 附錄B-1 BCA assay 校正曲線製作 143 附錄B-2 HGDC校正曲線製作 144 附錄C 超音波探針系統對於細胞釋放蛋白質之影響 145 附錄D 質體pREP4以及pQE1之質體構造圖 146 附錄E IPTG添加與否對於HGDC產量之影響 147 | |
| dc.language.iso | zh-TW | |
| dc.subject | 蛋白質純化 | zh_TW |
| dc.subject | 白內障 | zh_TW |
| dc.subject | 大腸桿菌 | zh_TW |
| dc.subject | 人類水晶體蛋白 | zh_TW |
| dc.subject | 親和性吸附 | zh_TW |
| dc.subject | E.coli | en |
| dc.subject | affinity purification | en |
| dc.subject | protein purification human γD crystallin | en |
| dc.subject | cataract; | en |
| dc.title | 表現與純化人類水晶體蛋白 | zh_TW |
| dc.title | Expression and Purification of Human γD crystallin | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 96-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 劉懷勝,王孟菊,賴進此,侯劭毅 | |
| dc.subject.keyword | 白內障,大腸桿菌,人類水晶體蛋白,蛋白質純化,親和性吸附, | zh_TW |
| dc.subject.keyword | cataract;,E.coli,protein purification human γD crystallin,affinity purification, | en |
| dc.relation.page | 147 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2008-07-29 | |
| dc.contributor.author-college | 工學院 | zh_TW |
| dc.contributor.author-dept | 化學工程學研究所 | zh_TW |
| 顯示於系所單位: | 化學工程學系 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-97-1.pdf 未授權公開取用 | 2.07 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
